0RAA Stock Overview
A medical technology company, engages in the design, manufacturing, and marketing of sterile implants and single-use sterile surgical instruments for the treatment of spinal surgery. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 1/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Safe Orthopaedics SA Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €0.063 |
52 Week High | €0.086 |
52 Week Low | €0.063 |
Beta | 1.45 |
1 Month Change | 0% |
3 Month Change | -21.45% |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | -100.00% |
Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
0RAA | GB Medical Equipment | GB Market | |
---|---|---|---|
7D | 0% | -3.5% | -2.6% |
1Y | n/a | -10.6% | 2.4% |
Return vs Industry: Insufficient data to determine how 0RAA performed against the UK Medical Equipment industry.
Return vs Market: Insufficient data to determine how 0RAA performed against the UK Market.
Price Volatility
0RAA volatility | |
---|---|
0RAA Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 6.5% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 10.6% |
10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0RAA's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 0RAA's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2010 | 138 | Pierre Dumouchel | www.safeorthopaedics.com |
Safe Orthopaedics SA, a medical technology company, engages in the design, manufacturing, and marketing of sterile implants and single-use instruments for the treatment of spinal fracture pathologies in France and internationally. The company’s products portfolio includes SteriSpine PS, an all-round kit for the treatment of spinal fractures and degenerative pathologies, as well as essential kit for percutaneous treatment of spinal fractures; SteriSpine VA, a product platform for ready to use Kyphoplasty and Cement systems; SteriSpine LC, a ready to use instrumentation for lumbar cage portfolio, including Cedar and Elm; and SteriSpine CC, a ready to use instrumentation for cervical cage, such as Walnut. Safe Orthopaedics SA was founded in 2010 and is headquartered in Éragny-sur-Oise, France.
Safe Orthopaedics SA Fundamentals Summary
0RAA fundamental statistics | |
---|---|
Market cap | €336.03k |
Earnings (TTM) | -€6.96m |
Revenue (TTM) | €5.86m |
0.1x
P/S Ratio0.0x
P/E RatioIs 0RAA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
0RAA income statement (TTM) | |
---|---|
Revenue | €5.86m |
Cost of Revenue | €1.76m |
Gross Profit | €4.11m |
Other Expenses | €11.07m |
Earnings | -€6.96m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | -0.62 |
Gross Margin | 70.06% |
Net Profit Margin | -118.84% |
Debt/Equity Ratio | -609.1% |
How did 0RAA perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2023/11/08 19:53 |
End of Day Share Price | 2023/08/11 00:00 |
Earnings | 2022/12/31 |
Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Safe Orthopaedics SA is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Arnaud Riverain | GreenSome Finance |
Martial Descoutures | Invest Securities |
Daniel Anizon | Invest Securities |